Preferences of Vaccination for COVID-19 Among University Students and Staff: A Discrete Choice Experiment

Preference, Patient Clinical Trial

Official title:

Preferences of Vaccination for COVID-19 Among University Students and Staff: A Discrete Choice Experiment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05150769
• Other study ID #: DCE_COVID-19
• Status: Completed
• Start date: July 21, 2021
• Est. completion date: September 21, 2021

Study information

• Verified date: December 2021
• Source: The University of Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

From March 2021, COVID-19 vaccines have been made available to Hong Kong residents, first to priority groups including healthcare professionals and the elderly, and later to all adults and adolescents. Vaccinated individuals are generally exempted from mandatory regular out-of-pocket antigen testing. Vaccinated individuals of university halls and colleges of The University of Hong Kong (HKU) will also be exempted from mandatory weekly antigen testing. Freedom of choice is highly respected in the HKU community and as such, we would like to better understand the decision-making process among members of the HKU community. The anonymised results of this independent research study will help us understand preferences among the HKU community and inform on future vaccination planning policies.

Objectives: To elicit HKU staff and students' preferences and their willingness-to-pay (WTP) for COVID-19 vaccination in Hong Kong

Design: An online cross-sectional internet-based questionnaire with a discrete choice experiment (DCE) design distributed via email. All current students and staff from the University of Hong Kong are eligible to participate in the study

Main outcome measures: Preferences for the efficacy of protecting against infection, against severe disease manifestations, duration of protection, risk of adverse events, incentives, and out-of-pocket costs

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3423
• Est. completion date: September 21, 2021
• Est. primary completion date: September 21, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years old

• Fluent in English

• Students and staff of The University of Hong Kong

Exclusion Criteria:

• Individuals who are younger than 18 years old

• Individuals who are unwilling to give consent

Related Conditions & MeSH terms

• Preference, Patient

Locations

Country	Name	City	State
Hong Kong	The University of Hong Kong	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Preferences for efficacy of protection against infection		At baseline
Primary	Preferences for efficacy of protection against severe disease manifestations		At baseline
Primary	Preferences for duration of protection		At baseline
Primary	Preferences for risk of adverse events		At baseline
Primary	Preferences for incentives		At baseline
Primary	Preferences for out-of-pocket cost		At baseline